Relive the launch of the Observatory of Good Regulatory Practices report and learn how Health Agencies are adopting WHO recommendations in the regulation of pharmaceutical products.
This study, is based on the Anexo 11 Buenas prácticas regulatorias en la regulación de productos médicos from the World Health Organization (WHO).
Measuring Regulatory Performance: A Practitioner’s Guide to Perception Surveys
OCDE: https://www.oecd.org/gov/regulatory-policy/LAC-Brochure-ESP.pdf
This study is an independent analysis of the adoption of Good Regulatory Practices (GPR) in the regulation of pharmaceutical products in eight (8) Latin American countries.
The information comes from reliable sources, however, the data and information described here will be subject to update and validation. This study is not an assessment of the maturity level of national drug regulatory authorities, nor does it substitute or replace official assessments conducted by authoritative bodies such as the World Health Organization (WHO) or the Pan American Health Organization (PAHO).
The findings are based on information available at the time of preparation and may be subject to change.
The study provides an overview of BPR in the countries analyzed and seeks to promote regulatory improvements.
The authors and the institution do not assume responsibility for decisions made based on this study.
The documents are copyrighted and non-commercial use is permitted with proper citation. By using these reports, you agree to the terms and conditions set forth in this legal notice and disclaimer.